인쇄하기
취소
|
Novartis, which has been suspected of providing KRW 2.6 billion rebates, will get a measure of restriction on the health insurance benefit.
The Ministry of Health and Welfare(MOHW) announced the Ministry of Food and Drug Safety(MFDS) will announce an administrative measure over the Novartis’ rebate case and the MOHW is also planning to restrict the health insurance benefit of its products that...